Quick Summary
Covering the latest research from top Wall Street investment banks

Citi downgrades China Pet to Sell, with margin pressure becoming the core issue

Institution
Citigroup
Date
2026-04-24
Authors
Tiffany Feng, Xiaopo Wei, CFA, Brian Cho
Company
China Pet (Yantai China Pet Foods)
Ticker
002891.SZ
Industry
Pet Food
Rating
Sell
BearishLow confidence4Q25 and 1Q26 net profit came in below expectations, with gross margin and net margin under pressure; management plans to step up investment in own-brand growth on the premise of avoiding losses, while overseas business is also facing unfavorable tariff and FX impacts, leading to substantial cuts to earnings forecasts and target price.
AuthorsTiffany Feng, Xiaopo Wei, CFA, Brian Cho
Target priceRmb23.6
Business segmentsOEM business、Own-brand business、Domestic market、Overseas market
Research firm divisions/subsidiariesCitigroup(Other)

AI summary card

Citi downgrades China Pet to Sell, with margin pressure becoming the core issue

The report believes China Pet's profits in 4Q25 and 1Q26 were both below expectations. Investment in own brands, OEM margins, tariffs, and FX factors are jointly pressuring earnings, so the rating is downgraded from Buy to Sell and the target price is cut from Rmb57.1 to Rmb23.6.

Rating: Sell; Target price: Rmb23.6; Current price: Rmb38.280; Expected share price return: -38.3%; Expected total return: -37.5%.
Rating downgradeMargin pressureEarnings forecast cutPet foodOwn-brand investment
  • 4Q25 net profit fell 72% YoY, revenue growth was only 7%, and gross margin, operating margin, and net margin all came in below expectations.
  • 1Q26 revenue grew 39% YoY, but this was mainly driven by temporary shipments and customer restocking; net profit fell 20% YoY, and gross margin declined by 5.1 percentage points.
  • Citi cut its 2026E/2027E net margin forecasts from 8.3%/8.2% to 5.4%/6.0%, and lowered net profit forecasts by 38%/33%.
  • The target price was cut to Rmb23.6, implying about 38.3% downside versus the current price of Rmb38.280, with expected total return of -37.5%.

Report interpretation

Overview

This is an earnings review report on China Pet. Citi believes the main issue in the company's recent results is not revenue, but margins coming in significantly below expectations: 4Q25 saw slowing revenue growth and a sharp drop in net profit; 1Q26 delivered high revenue growth but included temporary and restocking-related factors, while profitability remained weak. The report downgrades the company from Buy to Sell and sharply cuts the target price from Rmb57.1 to Rmb23.6.

Core views

The core view is that China Pet's earnings quality is being squeezed from multiple angles. The OEM business faces risks from a weaker US dollar, tariffs, and rising raw material costs; the own-brand business may require more aggressive selling and advertising investment to drive revenue growth. Management proposed pursuing high sales growth in the domestic business in 2026 on the premise of avoiding losses, but Citi believes this strategy could materially drag on net margin. Accordingly, the report cuts 2026E/2027E revenue forecasts by 5%/8% and net profit forecasts for the same periods by 38%/33%.

Analysis framework

The report analyzes the company from six angles: quarterly results, management outlook, business structure, margin changes, earnings forecast revisions, and valuation. On results, it focuses on comparing 4Q25 and 1Q26 revenue, gross margin, SG&A expense ratio, operating margin, and net margin; on valuation, it uses the DCF method and references the implied 2026E P/E.

Methodology notes

  • Valuation methodDCF

    Discounted cash flow valuation

    The target price of Rmb23.6 is based on a DCF model, assuming a WACC of 8.0%, including a risk-free rate of 2.0%, beta of 0.6, market risk premium of 9.0%, and a capital structure of 100% equity.

  • Relative valuationP/E

    Price-to-earnings ratio

    The Rmb23.6 target price implies about 22x 2026E P/E, used as a cross-check for the DCF valuation result.

  • Scenario analysisBull/Base/Bear

    Bull, base, and bear scenarios

    The report provides three scenario target prices of Rmb45.0, Rmb23.6, and Rmb20.0, corresponding respectively to revenue growth and EBIT margin coming in above, in line with, or below expectations.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

  • 002891.SZ
    Covered company in the report
    Strengths
    The company owns brands such as Wanpy Naughty, Zeal, and Toptrees, with products covering pet staple food, snacks, wet food, freeze-dried food, biscuits, chews, and dental care products, and exports to more than 60 countries and regions.
    Weaknesses
    Recent margins have come in significantly below expectations, own-brand growth may depend on higher selling and advertising investment, and the OEM business is affected by the US dollar, tariffs, and raw material costs.
    Comparison
    The report anchors valuation to a target price of Rmb23.6, implying about 22x 2026E P/E; compared with the current price of Rmb38.280, Citi sees significant downside.
    Risks
    If the macro environment improves, competition eases, raw material prices decline, US tariffs are reduced, or the renminbi depreciates, the share price could exceed the target price.

Key data

  • Rating changeDowngraded from Buy to SellThe report explicitly states D/G to Sell.
  • Target priceRmb23.6, previous Rmb57.1The target price was sharply lowered, mainly due to margin and earnings forecast cuts.
  • Current priceRmb38.280As of 2026-04-24 15:00.
  • Expected share price return-38.3%Excluding dividend yield.
  • Expected total return-37.5%Including an expected dividend yield of 0.9%.
  • 4Q25 net profitdown 72% YoYBelow expectations, mainly affected by weaker revenue growth and margins.
  • 1Q26 revenueup 39% YoYDriven by temporary factors and customer restocking, which the report views as unsustainable.
  • 2026E/2027E net margin forecast5.4%/6.0%Previously forecast at 8.3%/8.2%.
  • 2026E/2027E net profit forecast revisioncut by 38%/33%Mainly due to lower margins, while revenue forecasts were also cut by 5%/8%.
  • 2026E net profitRmb324mThe table shows 2026E reported net profit of Rmb324m.

Impact & implications

The report has negative implications for the stock: even if revenue continues to grow, the market may focus more on growth quality and margin sustainability. If own-brand growth relies on higher selling expenses, it may weaken net margin; if overseas business continues to face pressure from tariffs, FX, and costs, recovery in OEM profitability will also be constrained. The target price indicates clear downside versus the current price, reflecting Citi's view that current valuation has not yet fully priced in the risk of earnings downgrades.

Risks

  • Intensifying competition in the domestic market could require higher selling and advertising investment for own brands.
  • OEM business gross margin is affected by a weaker US dollar, tariffs, and rising raw material costs.
  • The strong 1Q26 revenue growth included temporary and restocking-related factors, so subsequent growth may be unsustainable.
  • Management did not provide a clear full-year 2026 net margin target, limiting earnings visibility.
  • If the macro environment improves, competition eases, raw material prices fall, US tariffs decline, or the renminbi depreciates, the actual share price may perform better than Citi's Sell view.

What to watch

  • Whether domestic own-brand revenue growth in 2026 can be achieved without incurring losses.
  • Whether selling and advertising expense ratios continue to rise, and their impact on net margin.
  • Whether OEM gross margin will be further dragged down by FX, tariffs, and raw material costs.
  • Whether the high revenue growth in 1Q26 driven by restocking will fall back in subsequent quarters.
  • Whether 2026E net margin can improve from the 1Q26 level to a range acceptable to management and the market.
  • Changes in US tariff policy, RMB exchange rates, and raw material prices.
Zhejiang ICP No. 2022035445-5
Disclaimer: Market data, charts, indicators, research views, and other information provided on this website are intended solely for information display, research communication, and educational reference. They should not be regarded as personalized investment advice, securities recommendations, trading instructions, solicitations, or guarantees of return. While we strive to improve the reliability of our data and content, such information may still be subject to delays, errors, incompleteness, or untimely updates due to source differences, methodological limitations, system processing, or market volatility. Users should exercise independent judgment based on their own circumstances and bear all risks and responsibilities arising from the use of this website.

Settings

Sign in to view recent logins